Revised SPC: Remicade (infliximab) 100mg powder for concentrate for solution for infusion -

Revised SPC: Remicade (infliximab) 100mg powder for concentrate for solution for infusion
Information type: Drug prescribing
Source: electronic Medicines compendium
Specialities: Gastrointestinal disorders | Musculo-skeletal disorders | Skin disorders | Vaccination
Summary
The SPC now warns that adults be brought up to date with all vaccinations prior to initiating treatment and to clarify patients on infliximab may receive concurrent vaccinations, except for live vaccines. Linear IgA Bullous Dermatosis has been added as a rare adverse reaction.
UKMi comment
Additional instructions for preparing Remicade for obese patients or patients weighing more than 100 kg at the higher 10 mg/kg dose have also been added to section 6.6.
Related links: